Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • 17 New Genetic Variants Linked To Parkinson's Disease

    17 New Genetic Variants Linked To Parkinson's Disease

    Researchers from 23andMe, Genentech and National Institute on Aging looked at DNA from 425,000 volunteers. These findings could lead to development of new drugs to stop PD.
    Learn more
  • Acorda Plans to Resubmit Inhaled Levodopa FDA Application Soon

    Acorda Plans to Resubmit Inhaled Levodopa FDA Application Soon

    Acorda received a Refusal to File letter from the FDA citing questions on when the manufacturing site will be ready and on the drug production record. They plan to refile their application soon.
    Learn more
  • Gene Therapy to Enhance Levodopa Response Progressing in Clinical Trials

    Gene Therapy to Enhance Levodopa Response Progressing in Clinical Trials

    Voyager Therapeutics today announced positive interim results from an ongoing trial testing a gene therapy that helps the brain make dopamine from levodopa.
    Learn more
  • Could an Asthma Drug Be the Way to Prevent Parkinson's?

    Could an Asthma Drug Be the Way to Prevent Parkinson's?

    Harvard researchers found a popular asthma drug may lower expression of a gene linked to Parkinson's disease and people who took the drug had lower risk of PD.
    Learn more
  • Stem Cells Safe in Pre-Clinical Parkinson's Disease Study

    Stem Cells Safe in Pre-Clinical Parkinson's Disease Study

    A study builds on the potential for stem cell therapy in Parkinson's disease, but more testing is needed.
    Learn more
  • First Drug Approved for Dyskinesia in Parkinson's Disease

    First Drug Approved for Dyskinesia in Parkinson's Disease

    Adamas Pharmaceuticals announced FDA approval of extended-release amantadine for levodopa-induced dyskinesia in PD.
    Learn more
  • Smell Loss and Dopamine Loss Predict Parkinson's Risk

    Smell Loss and Dopamine Loss Predict Parkinson's Risk

    A new paper shows 67% of study participants who showed smell loss and dopamine loss in the brain developed PD over a four-year period. This strategy could help select people for research studies.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.